Navigation Links
Santaris Pharma A/S Advances miravirsen, the First microRNA-Targeted Drug to Enter Clinical Trials, Into Phase 2 to Treat Patients Infected With Hepatitis C Virus
Date:9/22/2010

robust product pipeline targeting mRNAs and microRNAs both internally as well as in partnerships and collaborations with miRagen Therapeutics (cardiovascular diseases), Shire plc (rare genetic disorders), Pfizer (undisclosed therapeutic areas), GlaxoSmithKline (viral disease) and Enzon Pharmaceuticals (oncology).

About microRNAsMicroRNAs have emerged as an important class of small RNAs encoded in the genome. They act to control the expression of sets of genes and entire pathways and are thus thought of as master regulators of gene expression. Recent studies have demonstrated that microRNAs are associated with many disease processes. Because they are single molecular entities that dictate the expression of fundamental regulatory pathways, microRNAs represent potential drug targets for controlling many biologic and disease processes.

About Locked Nucleic Acid (LNA) Drug PlatformThe LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combines the Company's proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates against RNA targets, both mRNA and microRNA, for a range of diseases including metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders. The LNA Drug Platform overcomes the limitations of earlier antisense and siRNA technologies to deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. The unique combination of small size and very high affinity, which is only achievable with LNA-based drugs, allows this new class of drugs to potently and specifically inhibit RNA targets in many different tissues without the need for complex delivery vehicles. LNA-based drugs are a promising new type of therapy that enables scientists to develop drugs to attack previously inaccessible clinical pathways. The most important features of LNA-based drugs inc
'/>"/>

SOURCE Santaris Pharma A/S
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol
2. New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations
3. Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform
4. Santaris Pharma A/S Forms Strategic Alliance With Shire plc to Develop RNA-Based Medicines for the Treatment of Rare Genetic Disorders
5. Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
6. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark
7. Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
8. TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication
9. Keryx Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
10. Helix BioPharma Approved for NYSE Amex Listing
11. Optimer Pharmaceuticals Phase 3 Clinical Trials show Fidaxomicin is Superior to Vancomycin in Treatment of Recurrent Clostridium difficile Infection (CDI); Data Presented at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Oven Industries, Inc. has been an ... temperature sensors since 1964. Expertly designed, the proportional-integral-derivative ... system applications. As one of the most ... control loop feedback system, which helps minimize errors. With ... a systematic process, using a control element, like a ...
(Date:5/16/2013)... May 16, 2013 Cambridge Healthtech Institute ... August 19-23, 2013 at the Renaissance Waterfront Hotel in ... provide a close-up look at the current strategies and ... bottom-line quality. Leaders in the field will reveal ... produce biopharmaceuticals with greater specificity and efficiency. , “In ...
(Date:5/16/2013)... -- The registration deadline has been extended until May 22 ... Conference, the premier conference for bioscience financial officers. The ... San Diego Bayfront. "We are putting ... to make sure as many people as possible have ... , Chief Financial Officer of Mast Therapeutics, Inc. ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 On average, ... costs over one billion dollars. Despite this investment, less ... stakes this high, is your clinical trial design optimally ... the best outcomes? , Dr. Frederic Sax, Global Head ... discuss the use of data, information and technology in ...
Breaking Biology Technology:New PID Temperature Controllers Announced by Oven Industries Inc. 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... 7, 2008 BioSpace, the world,s,leading online bioscience ... host a Private Label Career Fair for Regeneron ... take place at the Hanover Marriott,in Whippany, New ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), Regeneron is ...
... SAN FRANCISCO, April 7, 2008 BioSpace, the ... career fair company,is hosting a Private Label Career ... Boston, Massachusetts. The event will be held at ... pm., (Logo: http://www.newscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), ...
... Bluestar Silicones,introduces a new range of Silbione(R) brand ... market that provide a unique combination,of strong physical ... durometers., These new low durometer products incorporate ... to 70- ShA LSR product,line, including easy processing, ...
Cached Biology Technology:BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey 2Boehringer Ingelheim and BioSpace Search for Scientists at Career Fair in Boston, Massachusetts 2Bluestar Silicones Introduces Three New Soft and Durable Liquid Silicone Rubber Products 2
(Date:5/16/2013)... to Research Careers) Program has announced the travel ... (SDB) 72nd Annual Meeting in Cancun, Mexico from ... promote the entry of students, postdoctorates and scientists ... basic science community and to encourage the participation ... Meeting. , Awards are given to poster/platform presenters ...
(Date:5/16/2013)... shorelines to predict the stability of today,s largest ice sheets ... three million years ago, for example when Earth was ... evidence of a high sea level due to ice sheet ... to think that if the world,s largest ice sheets collapsed ... in our modern, progressively warming world. , However, a ...
(Date:5/16/2013)... nanoparticles developed at MIT may someday eliminate the ... constantly monitor their blood-sugar levels and inject themselves ... sense glucose levels in the body and respond ... replacing the function of pancreatic islet cells, which ... Ultimately, this type of system could ensure that ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... routinely inside the body and see -- at the level ... distant dream. But in a series of experiments with genetically ... Medical Institute (HHMI) at the University of California Los Angeles ... demonstrating the ability to peer inside the body non-invasively and ...
... how healthy a life one leads, no person has managed ... advances of the modern age may have extended the average ... to longevity. One prominent theory of aging lays the blame ... by “free radicals,?highly reactive molecules produced by the metabolic activity ...
... The first close-up look at a pro-inflammatory signaling ... that researchers "should rethink what they are doing" ... scientists say. , Reporting in the Oct. 1 ... the University of Illinois at Urbana-Champaign unveiled the ...
Cached Biology News:PET imaging reveals the immune system at work 2PET imaging reveals the immune system at work 3Navigating the brain for sense of direction as paradigm for higher cognitive functions 2Molecular research suggest shift needed in how some drugs are created 2
... General description: Aminopropylsilane ... commonly used slide chemistry ... APS Coated Slides for ... reliable glass substrate for ...
Designed for use with any of the Agencourt kits in tube format....
... number is a new product number, ... number. If showing no availability yet, ... number (Z71,405-4) or contact customer service ... mm volume diam. 3 mL ...
... DAPI (4,6-diamidine-2-phenylindole, dihydrochloride) is ... the nucleus blue in color. ... excellent contrast to red fluorochromes ... Red, or R-Phycoerythrin. DAPI can ...
Biology Products: